Research Options:

Week of Expected Pricing 7/30/2021
Company Name RALLYBIO CORP
Proposed Ticker RLYB
CUSIP 75120L100
Business Description A clinical-stage biotechnology company built around a team of seasoned industry experts with a shared purpose and a track record of success in discovering, developing, manufacturing and delivering therapies that meaningfully improve the lives of patients suffering from severe and rare diseases. Our mission at Rallybio is aligned with our expertise, and we believe we have assembled the best people, partners and science to forge new paths to life-changing therapies.
Lead Underwriter Cowen and Company, LLC, Evercore Group L.L.C, Jefferies LLC
Co-Managers N/A
Initial Shares 57,50,000
Revised Initial Shares 62,00,000
Initial Price $13.00-$15.00
Revised Price N/A
Final Price $13.00
Final Ticker RLYB

 

 

   
  © 2024 ICE Data Services. All rights reserved.